Pharmafile Logo
Pharmafocus logo
Advanced Search

Vasella

Showing 7 posts of 7 posts found.

Novartis R&D: looking for the ‘Sweet Spot’

August 27, 2013
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis, R&D, Vasella

Feature

Vasella forgoes golden handshake after furore

February 19, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis, Vasella

Novartis has backed down over plans to pay outgoing chairman Dr Daniel Vasella a ‘golden handshake’ worth $77 million (72 …

News
Jimenez

Jimenez to take over as Novartis chief

January 28, 2010
Sales and Marketing Jimenez, Novartis, Vasella

Novartis’ long-standing chief executive and chairman, Daniel Vasella is to step down from his dual position to focus upon his …

News

Daniel Vasella, chief executive and chairman Novartis

September 17, 2009
Sales and Marketing Novartis, Vasella

Feature

Animal rights attacks were terrorism not activism, says Vasella

August 13, 2009
Research and Development, Sales and Marketing Animal tests, Novartis, Vasella

Novartis chief executive Daniel Vasella has spoken for the first time of his shock at the arson attack on his …

News

Vasella targeted by animal rights activists

August 6, 2009
Research and Development, Sales and Marketing Animal tests, Novartis, Vasella

Animal rights activists are believed to be behind two attacks on Novartis chief executive Daniel Vasella. The first attack came …

News
VasellaWEB

Vasella: on leadership

July 7, 2009
Sales and Marketing Novartis, Vasella, leadership, management

Novartis’ chief executive and chairman talks to McKinsey about his personal approach to management and leadership, and examines subjects including …

Feature

Latest content

Merck shares data from phase 3 trial of Keytruda for gastric cancers

May 2, 2024

Verona Pharma to share phase 3 COPD trial data at ATS 2024

May 2, 2024

Beckman Coulter Life Sciences and Watchmaker Genomics enter collaboration

May 1, 2024

Veru announces first patients enrolled in phase 2b trial for weight loss treatment

May 1, 2024

Bayer and Evotec to collaborate on precision cardiology

April 30, 2024